CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PATENTS ANALYSIS

3.3.1. Patent analysis by year
3.3.2. Patent analysis by region

3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET SHARE ANALYSIS

3.5.1. Cell-based assay market share (2012-2017)

3.6. MARKET DYNAMICS

3.6.1. Drivers
3.6.2. Restraints
3.6.3. Opportunities

CHAPTER 4 GLOBAL CELL-BASED ASSAY MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size & forecast

4.2. CONSUMABLES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast
4.2.4. Reagents

4.2.4.1. Market size & forecast

4.2.5. Microplates

4.2.5.1. Market size and forecast

4.2.6. Probes & Labels

4.2.6.1. Market size & forecast

4.2.7. Assay Kits

4.2.7.1. Market size & forecast

4.2.8. Cell Lines

4.2.8.1. Market size & forecast

4.2.9. Other Consumables

4.2.9.1. Market size & forecast

4.3. INSTRUMENTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size & forecast

4.4. SOFTWARE

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size & forecast

4.5. SERVICES

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size & forecast

CHAPTER 5 GLOBAL CELL-BASED ASSAY MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size & forecast

5.2. DRUG DISCOVERY

5.2.1. Market size & forecast

5.3. BASIC RESEARCH

5.3.1. Market size & forecast

5.4. ADME STUDIES

5.4.1. Market size & forecast

5.5. PREDICTIVE TOXICOLOGY

5.5.1. Market size & forecast

5.6. OTHER APPLICATIONS

5.6.1. Market size & forecast

CHAPTER 6 GLOBAL CELL-BASED ASSAY MARKET, BY END USERS

6.1. OVERVIEW

6.1.1. Market size & forecast

6.2. PHARMACEUTICAL COMPANIES

6.2.1. Market size & forecast

6.3. ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES

6.3.1. Market size & forecast

6.4. BIOTECHNOLOGY COMPANIES

6.4.1. Market size & forecast

6.5. OTHER END USERS

6.5.1. Market size & forecast

CHAPTER 7 GLOBAL CELL-BASED ASSAY MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size & forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size & forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size & forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size & forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Taiwan market size and forecast
7.4.3.7. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size & forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. BECTON DICKINSON AND COMPANY

8.1.1. Operating business segments
8.1.2. Business performance

8.2. THERMO FISHER SCIENTIFIC, INC

8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments

8.3. DANAHER CORPORATION,

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. GENERAL ELECTRIC COMPANY

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. MERCK KGAA

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. PERKINELMER, INC

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. BIO-RAD LABORATORIES, INC.

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. LONZA GROUP LTD

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. CELL SIGNALING TECHNOLOGY, INC.

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. PROMEGA CORPORATION

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments